Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.


Journal

European journal of cancer (Oxford, England : 1990)
ISSN: 1879-0852
Titre abrégé: Eur J Cancer
Pays: England
ID NLM: 9005373

Informations de publication

Date de publication:
01 2019
Historique:
received: 07 08 2018
revised: 28 10 2018
accepted: 01 11 2018
pubmed: 14 12 2018
medline: 6 5 2020
entrez: 14 12 2018
Statut: ppublish

Résumé

Increased values in the fecal immunochemical test (FIT) are correlated with increasingly severe colorectal neoplasia, but little attention has been given to FIT values below the cut-off point (negative FIT, nFIT). We analysed the relationship between the concentrations of two consecutive nFIT and the risk of following screen-detected advanced neoplasia and interval cancer (IC) in a population-based colorectal cancer screening program. FIT results were categorised into non-detectable nFIT (0-3.8 μg haemoglobin/g feces), low nFIT (3.9-9.9) and high nFIT (10.0-19.9). Multivariable adjusted logistic regression was used to estimate the odds ratios (OR) of advanced neoplasia and IC with the nFIT results in the first two screens. More than 90% of the 42,524 persons had non-detectable nFIT in the first and second screen; 4.5% and 5.8% had a low nFIT, respectively, and 2.2% and 2.9% had a high nFIT. The probability of testing positive and being diagnosed of advanced neoplasia or IC rose with increasing values of nFIT. Compared with those with two non-detectable nFIT results, the highest OR were found among those who had two high nFIT results (OR 21.75; 95% confidence interval: 12.44, 38.04) and those with one low nFIT and one high nFIT (ORs around 20). Participants with nFIT results above the detection limit of the test had an increased risk of advanced neoplasia and IC in subsequent participations. This information could be used in the design of personalised screening strategies.

Identifiants

pubmed: 30544059
pii: S0959-8049(18)31465-5
doi: 10.1016/j.ejca.2018.11.004
pii:
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-59

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Andrea Buron (A)

Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain. Electronic address: aburon@parcdesalutmar.cat.

Marta Román (M)

Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain.

Josep M Augé (JM)

Biochemistry and Molecular Genetics Department, Hospital Clínic, Barcelona, Spain; IDIBAPS (August Pi i Sunyer Biomedical Research Institute), Barcelona, Spain.

Francesc Macià (F)

Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain.

Jaume Grau (J)

Unit of Evaluation, Support and Prevention, Hospital Clinic, Barcelona, Spain.

Maria Sala (M)

Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain.

Javier Louro (J)

Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain.

Montserrat Martinez-Alonso (M)

Biomedical Research Institut of Lleida (IRBLLEIDA), Lleida, Catalonia, Spain.

Cristina Alvarez-Urturi (C)

Gastroenterology Department, Hospital del Mar, Barcelona, Spain.

Montserrat Andreu (M)

Gastroenterology Department, Hospital del Mar, Barcelona, Spain.

Xavier Bessa (X)

Gastroenterology Department, Hospital del Mar, Barcelona, Spain.

Diana Zaffalon (D)

Gastroenterology Department, Hospital del Mar, Barcelona, Spain.

Antoni Castells (A)

IDIBAPS (August Pi i Sunyer Biomedical Research Institute), Barcelona, Spain; Gastroenterology Department, Hospital Clínic, Barcelona, Spain; CIBERehd (CIBER for Digestive and Liver Diseases), Madrid, Spain.

Maria Pellisé (M)

IDIBAPS (August Pi i Sunyer Biomedical Research Institute), Barcelona, Spain; Gastroenterology Department, Hospital Clínic, Barcelona, Spain; CIBERehd (CIBER for Digestive and Liver Diseases), Madrid, Spain.

Marta Aldea (M)

Unit of Evaluation, Support and Prevention, Hospital Clinic, Barcelona, Spain.

Liseth Rivero (L)

IDIBAPS (August Pi i Sunyer Biomedical Research Institute), Barcelona, Spain; Gastroenterology Department, Hospital Clínic, Barcelona, Spain; CIBERehd (CIBER for Digestive and Liver Diseases), Madrid, Spain.

Cristina Hernández (C)

Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Isabel Torá-Rocamora (I)

Unit of Evaluation, Support and Prevention, Hospital Clinic, Barcelona, Spain.

Xavier Castells (X)

Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH